Dermata Therapeutics Cash Flow Statement 2019-2024 | DRMA

Fifteen years of historical annual cash flow statements for Dermata Therapeutics (DRMA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-7.79$-9.61$-7.90$-3.24$-4.72
$0$0$0.01$0.10$0.14
$0.52$0.93$1.91$-0.13$0.73
$0.52$0.93$1.92$-0.04$0.87
$0$0$0$0$0
$0$0$0$0$0
$0.37$-0.02$0.41$-0.23$0.12
$0.16$0.12$-0.75$-0.50$-0.20
$0.86$-0.15$0.29$-0.76$-0.08
$-6.41$-8.83$-5.69$-4.03$-3.92
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$1.01$2.30$-0.61
$0$0$0$0$0
$0$0$1.01$2.30$-0.61
$7.61$4.28$15.39$0$0
$7.61$4.28$14.96$0.27$5.36
$0$0$0$0$0
$0.00$0$0$0$-0.01
$7.61$4.28$15.96$2.57$4.73
$1.20$-4.56$10.27$-1.46$0.81
$0.52$0.93$1.91$0$0
$0$0$0$0$0